Piroxicam (oral)

Only for patients already established on piroxicam and in whom no suitable alternative can be found. The CHMP have recommended restrictions on the use of piroxicam because of the increases risk of GI side efefcts. Please refer to the BNF for further information

  • Traffic Light
    Grey
  • BNF
    10.3.2
  • Licensed Indicators
  • Reference
    APC Sept 15
  • Criteria
    3,6
  • Provisional
    No

Do you want to add this to your CPD record?

Did you find this page helpful?